https://www.selleckchem.com/pr....oducts/gsk484-hcl.ht
ion. To develop and validate Clinical Diversity In Meta-analyses (CDIM), a new tool for assessing clinical diversity between trials in meta-analyses of interventions. The development of CDIM was based on consensus work informed by empirical literature and expertise. We drafted the CDIM tool, refined it, and validated CDIM for interrater scale reliability and agreement in three groups. CDIM measures clinical diversity on a scale that includes four domains with 11 items overall setting (time of conduct/country development status/units
Like
Comment
Share
